Neuromuscular Disorders of Infancy, Childhood, and Adolescence - 2nd Edition - ISBN: 9780124170445, 9780124171275

Neuromuscular Disorders of Infancy, Childhood, and Adolescence

2nd Edition

A Clinician's Approach

Editors: Basil Darras H. Royden Jones, Jr. Monique Ryan Darryl De Vivo
Hardcover ISBN: 9780124170445
eBook ISBN: 9780124171275
Imprint: Academic Press
Published Date: 25th November 2014
Page Count: 1160
Tax/VAT will be calculated at check-out
200.00
125.00
143.00
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Description

Neuromuscular disorders are diagnosed across the lifespan and create many challenges especially with infants, children and adolescents. This new edition of the definitive reference, edited by the established world renowned authorities on the science, diagnosis and treatment of neuromuscular disorders in childhood is a timely and needed resource for all clinicians and researchers studying neuromuscular disorders, especially in childhood. The Second Edition is completely revised to remain current with advances in the field and to insure this remains the standard reference for clinical neurologists and clinical research neurologists. The Second Edition retains comprehensive coverage while shortening the total chapter count to be an even more manageable and effective reference.

Key Features

  • Carefully revised new edition of the classic reference on neuromuscular disorders in infancy, childhood and adolescence.
  • Definitive coverage of the basic science of neuromuscular disease and the latest diagnosis and treatment best practices.
  • Includes coverage of clinical phenomenology, electrophysiology, histopathology, molecular genetics and protein chemistry

Readership

Clinical Neurologists, Pediatric Neurologists, Neuroscience Researchers, Clinical Research Neurologists

Table of Contents

  • Dedication
    • About the Cover Images
  • Foreword
  • Preface to the Second Edition
  • Preface to the First Edition
  • List of Contributors
  • Part I: Clinical and Laboratory Approach to the Infant and Child with a Neuromuscular Problem
    • Chapter 1. Introduction: Historical Perspectives
      • Introduction
      • Traditional Diagnostic Tests
      • Modern Diagnostic Testing
      • Clinical Classification
      • Clinical Approach
      • Presenting Complaints
      • Conclusion
      • References
    • Chapter 2. Genetics of Neuromuscular Disorders
      • Introduction
      • Patterns of Genetic Transmission
      • Pedigree Analysis and Risk Assessment
      • Chromosomes and Chromosomal Abnormalities
      • Genetic Imprinting
      • Molecular Genetics
      • Gene Mutations and Modes of Inheritance
      • Developments in Molecular Diagnostics
      • Methods of Molecular Genetic Diagnostics
      • Comparison Between Panels and Whole Exome Sequencing
      • Secondary Findings
      • Clinical Indications for Genetic Testing
      • Approach to Genetic Evaluation
      • Potential Barriers to Testing
      • Attitudes Towards Genetic Testing
      • Recurrence Risk in Families and Reproductive Options
      • Treatment of Genetic Disorders
      • References
    • Chapter 3. Electromyography in Pediatrics
      • Introduction
      • Dealing with Misconceptions
      • Normative Data
      • Techniques
      • Investigation Strategies
      • Final Words
      • References
    • Chapter 4. Muscle Biopsy for Diagnosis of Neuromuscular and Metabolic Diseases
      • Introduction
      • Tissue Selection and Preparation
      • Ontogenesis of Striated Muscle
      • Cellular Death and Regeneration
      • Denervation, Disuse, and Hypotrophy
      • Muscle Biopsy in Specific Myopathies
      • Myofibrillar Myopathies
      • Glycogenoses
      • Lipid Storage Myopathies
      • Inflammatory Myopathies
      • References
    • Chapter 5. Nerve Biopsy
      • Introduction
      • Techniques
      • Complications
      • Age-Related Differences in Sural Nerve Morphology
      • Biopsy Findings in Relevant Diseases
      • Conclusion
      • References
  • Part II: Infantile Hypotonia and Arthrogryposis
    • Chapter 6. Neonatal Hypotonia
      • Introduction
      • History and General Examination
      • Neonatal Neuromuscular Examination
      • Distinguishing Features of Motor System Disorders
      • Conclusion
      • References
    • Chapter 7. Arthrogryposis
      • Introduction
      • Historical Background
      • Epidemiology
      • Pathogenesis
      • Clinical Features
      • Genotype/Phenotype Correlation
      • Arthrogryposis Associated with Maternal Illnesses
      • Therapy
      • Prognosis
      • Relatively Common Specific Conditions Associated with Multiple Congenital Contractures
      • Chromosomal Anomalies
      • Maternal Antibodies with and Without Myasthenia Gravis
      • Acknowledgments
      • References
  • Part III: Motor Neuron Disorders
    • Chapter 8. Spinal Muscular Atrophies
      • Introduction
      • Epidemiology
      • Clinical Characteristics
      • Genetics
      • Other Diagnostic Tests
      • Molecular Function of SMN
      • Differential Diagnosis
      • The Pathology of SMA
      • Animal Models
      • Treatment
      • Care of the Patient with SMA
      • Conclusion
      • Acknowledgments
      • References
    • Chapter 9. Juvenile Amyotrophic Lateral Sclerosis
      • Introduction
      • Nosology of Motor Neuron Diseases
      • Discussion of Table 9.1
      • Management
      • Genetic Counseling
      • Conclusions
      • References
    • Chapter 10. Infectious or Acquired Motor Neuron Diseases
      • Infantile Poliomyelitis
      • Vaccine-Associated Poliomyelitis
      • Tetanus: A Combined Perspective from South Africa and North America
      • Rabies
      • References
    • Chapter 11. The Stiff-man Syndrome in Children and Adolescents
      • Introduction
      • Historical Perspective
      • Epidemiology
      • Pathophysiology
      • Neurological Presentation
      • Coexisting Autoimmune Diseases
      • Oncological Findings
      • Differential Diagnosis
      • Testing
      • Treatment
      • Prognosis
      • Conclusion
      • References
  • Part IV: Peripheral Nerve Disorders
    • Chapter 12. Radiculopathies and Plexopathies
      • Anatomy
      • Diagnostic Procedures
      • Cervical Radiculopathies
      • Lumbosacral Radiculopathies
      • Plexopathies
      • References
    • Chapter 13. Congenital and Acquired Facial Palsies
      • Introduction
      • Evaluation of the Facial Nerve in Children
      • Congenital Facial Palsies
      • Acquired Facial Palsies
      • References
    • Chapter 14. Mononeuropathies
      • Introduction
      • Assessment and Evaluation of Peripheral Nerve Lesions in Childhood
      • Upper Extremity Mononeuropathies
      • Lower Extremity Mononeuropathies
      • References
    • Chapter 15. Overview of Pediatric Peripheral Neuropathies
      • Introduction
      • Approach to Evaluating Childhood Neuropathies
      • Pediatric Electrodiagnostic Testing
      • Trauma
      • Nerve Biopsy
      • Neuroimaging in Childhood Polyneuropathies
      • References
    • Chapter 16. Congenital and Early Infantile Neuropathies
      • Introduction
      • Etiology
      • Clinical Presentation and Approach to Peripheral Neuropathies in Early Infancy
      • Genetic Demyelinating Neuropathies with Infantile Onset
      • Demyelinating Neuropathies of Infancy Associated with Central Nervous System Involvement
      • Genetic Axonal Neuropathies with Infantile Onset
      • Conclusion
      • Acknowledgments
      • References
    • Chapter 17. Hereditary Neuropathies in Late Childhood and Adolescence
      • Definition and Nomenclature
      • Epidemiology
      • Pathobiology
      • Clinical Manifestations
      • Neurophysiology
      • Genetic Testing and Diagnostic Strategies
      • Specific Forms of CMT
      • Differential Diagnosis
      • Treatment Strategies
      • Summary
      • References
    • Chapter 18. Hereditary Sensory and Autonomic Neuropathies
      • Introduction
      • Hsan Type I
      • Hsan Type II
      • Hsan Type III
      • Hsan Type IV
      • Hsan Type V
      • Diagnosis of an Hsan
      • Therapeutic Interventions
      • References
    • Chapter 19. Peripheral Neuropathy in Inherited Metabolic Disease
      • Introduction
      • Lysosomal Storage Diseases
      • Peroxisomal Storage Diseases
      • Diseases of Lipids and Lipoproteins
      • Glycogen Storage Disease
      • Amino Acid Disease
      • Mitochondrial Diseases
      • Other Inherited Metabolic Diseases
      • References
    • Chapter 20. Acute Polyneuropathies
      • Introduction
      • Guillain-Barré Syndrome
      • Tick Paralysis
      • References
    • Chapter 21. Chronic Inflammatory Demyelinating Polyradiculoneuropathy
      • Epidemiology
      • Pathogenesis
      • Clinical Features
      • Differential Diagnosis
      • Laboratory Studies
      • Electrophysiologic Testing
      • Nerve Biopsy
      • Neuroimaging
      • Treatment
      • Prognosis
      • References
    • Chapter 22. Neuropathies Secondary to Systemic Disorders
      • Introduction
      • Critical Illness Polyneuropathy
      • Renal Disorders
      • Endocrine Disorders
      • Vitamin Deficiency States
      • Malignancies and Reticuloses
      • Connective Tissue Disorders
      • Miscellaneous Systemic Disorders
      • References
    • Chapter 23. Toxic Neuropathies
      • Introduction
      • General Features of Toxic Neuropathies
      • Selected Toxic Neuropathies
      • Conclusion
      • References
    • Chapter 24. Hansen’s Disease (Leprosy): Leprous Neuropathy
      • Introduction
      • Skin Manifestations
      • Leprosy Neuropathy
      • Diagnosis
      • Pathophysiology of Nerve Damage
      • Treatment
      • References
  • Part V: Neuromuscular Junction Disorders
    • Chapter 25. Acquired Presynaptic Neuromuscular Junction Disorders: Infant Botulism and Lambert-Eaton Myasthenic Syndrome
      • Infant Botulism
      • Lambert-Eaton Myasthenic Syndrome
      • Summary
      • References
    • Chapter 26. Congenital Myasthenic Syndromes
      • Introduction
      • Diagnosis
      • Classification
      • Presynaptic Congenital Myasthenic Syndrome
      • Synaptic Basal Lamina Associated CMS
      • Postsynaptic CMS
      • Currently Available Therapies
      • References
    • Chapter 27. Juvenile and Neonatal Myasthenia Gravis
      • Background
      • Pathophysiology
      • Clinical Presentation
      • Diagnostic Testing
      • Medical Therapies
      • Surgical Therapies
      • Neonatal Myasthenia Gravis and the Fetal Acetylcholine Receptor Inactivation Syndrome
      • Prognosis
      • Conclusions
      • References
  • Part VI: Myopathies
    • Chapter 28. Congenital and Other Structural Myopathies
      • Nemaline Myopathy
      • Core Myopathies
      • Multiminicore Disease
      • Congenital Fiber Type Disproportion
      • Centronuclear Myopathies
      • Titinopathies
      • Myofibrillar Myopathies
      • Hyaline Body Myopathy
      • Autophagic Vacuolar Myopathies
      • Treatment of Congenital Myopathies
      • Novel Therapeutic Strategies
      • Drug Discovery
      • References
    • Chapter 29. Congenital Muscular Dystrophies
      • Introduction
      • Merosin-Deficient CMD
      • Dystroglycanopathies
      • CMD With Collagen VI Deficiency (Ullrich Disease)
      • SEPN1-Related CMD
      • LAMIN A/C-Related CMD
      • Differential Diagnosis
      • Therapeutic Approaches
      • Acknowledgments
      • References
    • Chapter 30. Dystrophinopathies
      • Introduction
      • Etiology and Pathogenesis
      • Incidence and Prevalence
      • Clinical Presentation
      • Differential Diagnosis
      • Diagnostic Testing
      • Treatment and Management
      • References
    • Chapter 31. Clinical Management of Dystrophinopathies: A Systematic Approach
      • Introduction
      • Duchenne Muscular Dystrophy
      • Other Dystrophinopathies: Becker Muscular Dystrophy and Manifesting Carriers of DMD/BMD
      • Conclusions
      • References
    • Chapter 32. Facioscapulohumeral Dystrophy
      • Introduction
      • Clinical Features
      • Extramuscular Manifestations
      • Infantile FSHD
      • FSHD Variants
      • Scapulohumeral Dystrophy Phenotype with Facial Sparing
      • Differential Diagnosis
      • Laboratory Tests
      • Management
      • Prognosis
      • Genetics
      • References
    • Chapter 33. Distal Myopathies
      • Early Onset Distal Myopathies
      • Juvenile Onset Distal Myopathies
      • References
    • Chapter 34. Limb-girdle Muscular Dystrophies
      • Introduction
      • Autosomal Recessive Limb-Girdle Muscular Dystrophies
      • Autosomal Dominant LIMB-Girdle Muscular Dystrophies
      • Other Muscular Dystrophies that May Present as LGMD
      • Summary and Approach to Patients
      • References
    • Chapter 35. Emery-Dreifuss Muscular Dystrophy: Nuclear Envelopathies
      • Introduction
      • Historical Background
      • Molecular Biology
      • Pathogenesis
      • Clinical Features
      • Differential Diagnosis
      • Genotype-Phenotype Correlation
      • Laboratory Investigations
      • Therapy
      • Prognosis
      • Acknowledgments
      • References
    • Chapter 36. Myopathies of Systemic Disease
      • Introduction
      • Hyperthyroidism
      • Hypothyroidism
      • Parathyroid Disease
      • Cushing’s Syndrome
      • Uremia
      • Osteomalacia
      • Hypokalemia
      • Hypernatremia
      • Primary Hyperparathyroidism
      • Human Immunodeficiency Virus
      • Lyme Disease
      • Sepsis/Intensive Care Unit Myopathies
      • Medication-Related Myopathies
      • Inflammatory Myopathies Associated with Systemic Disorders
      • Eosinophilic Myopathic Syndromes
      • References
    • Chapter 37. Myotonic Dystrophy
      • Clinical Presentation and Phenotypes
      • Molecular Genetics
      • Diagnostic Approach
      • Management
      • References
    • Chapter 38. Muscle Channelopathies: Myotonias and Periodic Paralyses
      • Introduction
      • Electrophysiology of Clinical Weakness and Paralysis
      • Myotonias
      • Paramyotonia
      • Periodic Paralyses
      • Acknowledgments
      • References
    • Chapter 39. Glycogen Storage Diseases of Muscle
      • Introduction and Background
      • Forearm Ischemic Exercise Test
      • Defects of Glycogenolysis
      • Defects of Glycolysis
      • Defects of Glycogen Synthesis
      • Defects of Lysosomal Glycolysis
      • References
    • Chapter 40. Lipid Storage Myopathies Due to Fatty Acid Oxidation Defects
      • Historical Background
      • Pathophysiology
      • Clinical and Biochemical Features of Identified Defects
      • Differentiating Laboratory Features
      • Diagnostic Approaches and Screening Methods
      • Treatment
      • Genetics and Presymptomatic Recognition
      • Conclusion
      • Acknowledgments
      • References
    • Chapter 41. Mitochondrial Encephalomyopathies
      • Introduction
      • Diseases Due to mtDNA Mutations
      • Diagnostic Approach
      • Therapeutic Approaches
      • References
    • Chapter 42. Juvenile Dermatomyositis and Other Inflammatory Myopathies in Children
      • Introduction
      • The Epidemiology of the Major Pediatric Inflammatory Myopathies
      • Pathogenesis/Genetic Data
      • Course and Therapy
      • Other Less Common Forms of Inflammatory Myopathy
      • Conclusion
      • References
  • Part VII: Special Clinical Problems
    • Chapter 43. Neuromuscular Problems of the Critically Ill Neonate and Child
      • Introduction
      • Acute Neuromuscular Crises in the Infant
      • Acute Neuromuscular Crises in the Toddler and the Older Child
      • Critical Illness Neuromuscular Disorders
      • Conclusions
      • References
    • Chapter 44. Intensive Care Management, Including Cardiorespiratory Care
      • Historical Background
      • Intensive Care
      • Ethics
      • Normal Physiology
      • Pathophysiology
      • Evaluation
      • Treatment
      • References
    • Chapter 45. Malignant Hyperthermia: An Inherited Disorder of Muscle Calcium Metabolism
      • Malignant Hyperthermia—Deaths in General Anesthesia
      • Muscular Hypermetabolism by Rampant Ca2+
      • Anesthesia-Related Muscle Spasms
      • Awake Episodes
      • MH and Childhood
      • Functional Diagnostics—In Vitro Contracture Test
      • Genetic Diagnostics
      • Creatine Phosphokinase
      • Histological Findings and Core Formation
      • Associated Syndromes and MH-Like Episodes
      • Clinical Considerations
      • References
    • Chapter 46. Disorders of the Ocular Motor Cranial Nerves and Extraocular Muscles
      • General Principles
      • The Extraocular Lower Motor Unit
      • Examination Approach to Extraocular Movement Disorders
      • Cranial Nerve Palsies
      • Congenital Ptosis Syndromes
      • Congenital Cranial Dysinnervation Disorders
      • Synkinesis Syndromes
      • Ophthalmoplegia in Pediatric Neuromuscular Disease
      • References
    • Chapter 47. Oromotor Dysfunction in Neuromuscular Disorders: Evaluation and Treatment
      • Introduction
      • Oromotor Dysfunction Due to Neuromuscular Disorders
      • Neuromuscular Disorders with Associated Oromotor Dysfunction
      • OMS Dysfunction Assessment
      • Treatment of Oromotor Dysfunction Due to a Neuromuscular Disorder
      • References
    • Chapter 48. Complex Regional Pain Syndromes I and II (Reflex Sympathetic Dystrophy, Causalgia)
      • Introduction
      • Incidence and Prevalence
      • Pathophysiology
      • Diagnosis
      • Treatment
      • Prognosis
      • References
    • Chapter 49. Friedreich Ataxia
      • Introduction
      • Epidemiology
      • Pathology
      • Clinical Aspects
      • Differential Diagnosis
      • Molecular Genetics
      • New Approaches to Treatment
      • References
    • Chapter 50. Dominantly Inherited Spinocerebellar Syndromes
      • Introduction
      • SCAs Caused by Polyglutamine Expansions
      • SCAs Caused by Other (Nonpolyglutamine) Repeat Expansions
      • SCAs Caused By Missense Mutations
      • SCAs of Unknown Cause
      • Episodic Ataxias
      • Clinical Case Descriptions
      • Diagnosis
      • Therapy
      • Acknowledgments
      • References
  • Part VIII: General Therapeutic Principles
    • Chapter 51. Principles and Practice of Molecular Therapies
      • Introduction
      • Newborn Screening for Muscular Dystrophy: The Key to Making a Therapeutic Difference
      • Gene Repair through Exon Skipping and Mutation Suppression
      • Ignoring Stop Codons Using Small Molecules
      • Gene Replacement Strategies Targeting Specific Muscular Dystrophies
      • Vascular Delivery to Improve Clinical Outcomes
      • Therapeutic Enhancement Using Surrogate Genes
      • Strategies responsive to Immunity of AAV and/or Transgene
      • Summary
      • Acknowledgments
      • References
    • Chapter 52. Orthopedic Management
      • Introduction
      • Spinal Muscular Atrophy
      • Hereditary Sensory and Motor Neuropathies
      • Friedreich Ataxia
      • Duchenne Muscular Dystrophy
      • Becker Muscular Dystrophy
      • Congenital Myotonic Dystrophy
      • Congenital Myopathies
      • Arthrogryposis
      • Cerebral Palsy
      • References
    • Chapter 53. Rehabilitation of the Child with a Neuromuscular Disorder
      • Introduction
      • Rehabilitation Goals and Programs
      • Rehabilitation Therapies
      • Assistive Devices
      • Assistive Technology
      • Alternative Therapies
      • Conclusion
      • References
    • Chapter 54. Outcome Measures in Neuromuscular Diseases
      • Introduction: What are Outcome Measures?
      • Outcome Measures in Different Stages of Therapeutics Development
      • Clinical Outcome Measures
      • Potential Biomarkers
      • Patient Reported Outcome Measures
      • Conclusions
      • References
  • Index

Details

No. of pages:
1160
Language:
English
Copyright:
© Academic Press 2015
Published:
Imprint:
Academic Press
eBook ISBN:
9780124171275
Hardcover ISBN:
9780124170445

About the Editor

Basil Darras

Dr. Basil T. Darras is Associate Neurologist-in-Chief and Chief of the Division of Clinical Neurology at Boston Children’s Hospital, and the Joseph J. Volpe Professor of Neurology at Harvard Medical School. Dr. Darras is a pediatric neurologist with advanced training and certification in human genetics and neuromuscular medicine. At Boston Children’s he serves as Director of the Neuromuscular Program, which includes one of the oldest and most active muscular dystrophy clinics in the country and where he specializes in the care of children with neuromuscular conditions originating from inherited or acquired conditions of the motor unit. He has published over 140 original reports in peer-reviewed journals and over 70 chapters, reviews and editorials; his major publications and specific research interests have focused on the molecular genetics, diagnostics, and therapeutics of Duchenne and Becker muscular dystrophies and spinal muscular atrophy, and on defining the indications for new diagnostic methodologies in the evaluation of children with pediatric neuromuscular diseases. Basic research, carried out in collaboration with scientists in the research laboratories of Boston Children’s and other institutions, focuses on the description of novel mutations in patients with neuromuscular diseases and the application of new technologies to explore the pathogenesis and treatment of congenital myopathies and muscular dystrophies. Dr. Darras is site PI for the consortium conducting Pediatric Neuromuscular Clinical Research in Spinal Muscular Atrophy, and site PI/PD for the NeuroNEXT NINDS Program. He is currently involved in multiple clinical trials of novel genetic interventions for the treatment of spinal muscular atrophy and Duchenne muscular dystrophy.

Affiliations and Expertise

Children's Hospital, Boston, MA, USA

H. Royden Jones, Jr.

Dr. H. Royden Jones was Chair of the Department of Neurology at Lahey Hospital and Medical Center, Burlington, Massachusetts; Director of the Electromyography Laboratory at Boston Children’s Hospital; and Clinical Professor of Neurology at Harvard Medical School. Dr. Jones completed residencies in Internal Medicine and Neurology and a fellowship in neurological physiology at the Mayo Clinic. He served over 3 years in the United States Army as Chief of Neurology at 5th General Hospital, Bad Cannstatt, Germany. Dr. Jones was Board certified in neurology, clinical neurophysiology, and neuromuscular medicine. Upon completion of his training he joined the Lahey Clinic in 1972. In 1977 he also joined the neurology department at Boston Children’s Hospital, founding the electromyography laboratory in 1979. Pediatric EMG became his major clinical research interest. Dr. Jones was co-editor of three major textbooks on childhood clinical neurophysiology and neuromuscular disorders. He was a co-founder of the biennial International Paediatric EMG Conference based at Great Ormond Street Children’s Hospital, London, England. Recognized as one of the top neurologists in the U.S., Dr. Jones was an author and editor of several Netter publications including two editions of Netter’s Neurology, The Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part I (Brain) and Part II (Spinal Cord and Peripheral Motor and Sensory Systems), 2nd Editions (volumes in the Netter Green Book Collection). Dr. Jones authored and edited several other Netter publications and contributed over 200 peer-reviewed papers and book chapters. Dr. Jones served 8 years as a director of the American Board of Psychiatry and Neurology, becoming Chair of its Neurology Council in 2004. In 2007 he received the Distinguished Physician Award from the American Association of Neuromuscular and Electrodiagnostic Medicine. Lahey Clinic’s Medical Staff Association recognized Dr. Jones in 2010 with its highest honor—the Frank Lahey Award for “commitment to the values of Dr. Frank Lahey: respect, teamwork, excellence, commitment to personal best.” Dr. Jones was named Outstanding Teacher in Pediatric Neurology 2012 – 2013 by the Department of Neurology, Boston Children’s Hospital, Harvard Medical School. He also received an award in recognition of his many years of dedicated teaching at Tufts University School of Medicine.

Affiliations and Expertise

Children's Hospital, Boston, MA, USA

Monique Ryan

Associate Professor Monique Ryan is a paediatric neurologist in the Children’s Neurosciences Centre, Royal Children’s Hospital, Melbourne Australia, where she is head of the neuromuscular clinical research program and multidisciplinary Neuromuscular Clinic. This clinic oversees the care of more than 500 children with neuromuscular disorders. A/Prof Ryan’s research interests include natural history studies of paediatric neuropathies and clinical trials of new therapies for muscle diseases, neuropathies and myasthenic syndromes of childhood. Her group undertook the landmark initial study of treatment of paediatric Charcot-Marie-Tooth disease type 1A with ascorbic acid, the first randomized, double-blind placebo-controlled therapeutic trial in paediatric CMT. Other research trials previously or currently undertaken at RCH include trials of novel therapeutics for Duchenne muscular dystrophy and spinal muscular atrophy, a number of studies addressing the natural history of various forms of paediatric CMT, and studies identifying new genes for CMT. A/Prof Ryan is a member of several international neuromuscular research consortia, a board member of CINRG and a member of the extended TREAT-NMD therapeutic advisory committee.

Affiliations and Expertise

Royal Children's Hospital, Parkville, Victoria, Australia

Darryl De Vivo

Dr. Darryl C. De Vivo is the Sidney Carter Professor of Neurology, Professor of Pediatrics, and Director Emeritus (1979-2000) of the Pediatric Neurology Service at the Columbia University Medical Center in New York City. He also serves as the Associate Chairman for Pediatric Neurosciences and Developmental Neurobiology, the Founding Director of the Colleen Giblin Research Laboratories for Pediatric Neurology, and the Co-Director of the Center for Motor Neuron Biology and Disease (MNC). Dr. De Vivo was a Director for Neurology and President of the American Board of Psychiatry and Neurology, Secretary of the American Academy of Neurology, and President of the Child Neurology Society. He completed postgraduate training in medicine at the University of Virginia Medical School, and residency training in medicine, pediatrics, and neurology at the Massachusetts Memorial Hospital and the Massachusetts General Hospital, and at the National Institutes of Health where he was a Clinical Associate in Neurology. Dr. De Vivo receives federal and non-federal funding, and serves as the Director for the Pediatric Neuromuscular Clinical Research Network (PNCRN) in Spinal Muscular Atrophy. He has published more than 400 original articles and reviews, lectures extensively in the U.S. and abroad, and serves on several editorial boards and advisory committees. He was honored in 2014 by the American Academy of Neurology as the recipient of the Sidney Carter Award in Pediatric Neurology. He has devoted part of his professional career to the study of neuromuscular diseases. In 1967, he studied at the NINDS as a clinical associate under W. King Engel. In 1975, he and Michael Brooke established the Jerry Lewis Neuromuscular Disease Center at Washington University School of Medicine. In 1979, Dr. De Vivo established the Pediatric Neuromuscular Disease Center at the Columbia University Medical Center, and in 2004, with support from the New York-based SMA Foundation, the Center was expanded to include the SMA Clinical Research Center, an intramural affiliate of the MNC. Recently, the PNCRN, established in 2004, has been expanded to six academic sites at Columbia, Harvard, Penn, Rochester, Nemours/Orlando and Stanford. This network is dedicated to the acceleration of clinical trials in search of effective treatments for SMA.

Affiliations and Expertise

Columbia University Medical Center, New York, NY, USA